1. HBW Insight
  2. >>Beauty
  3. >>Innovation & IP

L'Oreal's UV Sense Doubles As Sun Exposure Monitor, Thumbnail Art

 
• By Ryan Nelson

Measuring less than 2mm thick and 9mm in diameter, UV Sense is intended to be worn on a user’s thumbnail for up to two weeks at a time, relaying UV exposure measurements to a companion app that organizes the data and offers protective care recommendations. The device will launch from La Roche-Posay on a limited basis in the US this summer.

Innovation concept presented by a consultant in management on webinar screen

L'Oreal SA is building on experience gleaned from My UV Patch – distributed free of charge to consumers last year – with the coming launch of UV Sense, a next-level device that stores up to three months of data.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Innovation & IP

More from Beauty

Stakeholders Hope US FDA’s Proposed Animal Test Phase-Out For Drugs Will Extend To OTCs, Cosmetics

 
• By Eileen Francis and Lauren Nardella

The US Food and Drug Administration has released a roadmap to adopt new approach methodologies in lieu of animal testing for monoclonal antibody therapies and other drugs, which may include OTC drugs though the proposal does not specifically include cosmetics.

Coty’s Next Phase Of ‘All-In To Win’ Strategy Should Generate $130M Savings

 
• By Eileen Francis

Coty’s ‘All-in to Win’ program enters the next phase, which sets aggressive savings over the next two years in part by simplifying and scaling its operating model, in addition to boosting its innovation impact.

P&G: Innovation, Pricing ‘Short-Term Levers’ For Tariffs Adding Up To $1.5Bn In Costs Annually

 
• By Eileen Francis

The Procter & Gamble Company is working to mitigate the impact of tariffs, which will add up to $1.5bn in costs annually. The firm has lowered its fiscal 2025 outlook.